Browse All
Displaying 1 - 4 of 4
Author:Oh, Jiwon Bar-Or, Amit Giovannoni, Gavin Sormani, Maria Pia Weber, Martin S. Stoll, Sharon Nicholas, Jacqueline A. von Büdingen, H.-Christian Decker-Palmer, Marquita Loukitcheva, Anastasia Triyatni, Miriam Hu, Nan Ratchford, John N. Napieralski, Julie Goodyear, Alexandra Kappos, Ludwig Hauser, Stephen
Session Name:LS2: Late-breaking Science 2
Topic:Multiple Sclerosis
Program Number:LS2.005
Author Institution:St. Michael's Hospital, University of Toronto, Toronto, ON, Canada Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA Queen Mary University of London, London, United Kingdom University of Genoa, Genoa, Italy Institute of Neuropathology and Department of Neurology, University Medical Center and Fraunhofer Institute for Translational Medicine and Pharmacology , Göttingen, Germany Advocare Stoll Medical Group, Philadelphia, PA OhioHealth Multiple Sclerosis Centre, Riverside Methodist Hospital, Columbus, OH F. Hoffmann-La Roche Ltd, Basel, Switzerland Genentech, Inc., South San Francisco, CA University Hospital and University Basel, Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Basel, Switzerland University of California San Francisco, San Francisco, CA
Author:Pluvinage, John Acero-Garces, David Greco, Giacomo Moseley, Carson Cree, Bruce Hauser, Stephen DeRisi, Joseph Pleasure, Samuel Gelfand, Jeffrey Alvarez-Bravo, Gary Gastaldi, Matteo Pardo-Villamizar, Carlos Wilson, Michael
Session Name:S6: Autoimmune Neurology: NMOSD and MOGAD
Topic:Autoimmune Neurology
Program Number:S6.003
Author Institution:UCSF, CA Johns Hopkins University, Baltimore, MD University of Pavia, Pavia, Italy University of California, San Francisco, San Francisco, CA UCSF, Multiple Sclerosis Center, San Francisco, CA UCSF Weill Institute for Neurosciences, San Francisco, CA UCSF, San Francisco, CA University of Girona, Girona, Spain IRCCS Mondino Foundation, Pavia, Italy Johns Hopkins U, Med Dept of Neurology, Baltimore, MD University of California San Francisco, San Francisco, CA
Author:Pardo, Gabriel Montalban, Xavier Cohen, Jeffrey Morrow, Sarah Li, Jun Carr, David Pearce, Gregory Solonets, Maria Abeyewickreme, Anil de Seze, Jérôme Nakahara, Jin Wiendl, Heinz Hauser, Stephen
Session Name:P9: Multiple Sclerosis: Clinical Trials 2
Program Number:P9.006
Author Institution:Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Oklahoma City, OK Department of Neurology/Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada, calgary, AB, Canada Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland IQVIA RDS GmbH, Frankfurt, Germany, Germany Novartis Pharmaceuticals UK Ltd, London, United Kingdom, London, United Kingdom University Hospital of Strasbourg, Strasbourg, France, Strasbourg, France Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Klinik für Neurologie und Neurophysiologie, Universitätsklinikum Freiburg, Freiburg, Germany, Freiburg im Breisgau, Germany UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA, San Francisco, CA
Author:Morales-Rodriguez, Denisse Silverman, Hannah Campagna, Maria Pia Nylander, Alyssa Akula, Amit Gomez, Refujia Santaniello, Adam Renschen, Adam Harms, Meagan Cooper, Tiffany Lincoln, Robin Poole, Shane Henry, Roland Hauser, Stephen Cree, Bruce Bove, Riley
Session Name:P11: Multiple Sclerosis: Sex and Gender Informed Neurology
Program Number:P11.008
Author Institution:UCSF Weill Institute for Neurosciences, San Francisco, CA
